Skip to main content
. 2021 Jan 18;7:16. doi: 10.1038/s41420-020-00393-w

Fig. 2. Inhibition of AURKB activity during early and late development of the embryonic submandibular glands.

Fig. 2

Inhibition of AURKB using Barasertib in the early (AC) and late E-SMGs (D, E). Treatment of the explants with Barasertib for 24h reduced Spooner ratio in the early explants (B) and inhibited expansion of SMG buds in a dose-dependent manner (C, E). Analysis demonstrated gradual reduction of the mean total bud area with increasing doses of Barasertib, which was more clearly seen in the mature explants (late development) (D, E), n = 3 for each group. All downstream experiments were conducted using Barasertib at 1 µM (red outline).